Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Surmodics Inc 9924 WEST 74TH STREET EDEN PRAIRIE MN 55344 USA

www.surmodics.com Employees: 376 P: 952-500-7000 F: 952-500-7001

Description:

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.'The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.

Key Statistics

Overview:

Market Capitalization, $K 544,571
Enterprise Value, $K 532,561
Shares Outstanding, K 14,267
Annual Sales, $ 126,080 K
Annual Net Income, $ -11,540 K
Last Quarter Sales, $ 33,230 K
Last Quarter Net Income, $ -3,450 K
EBIT, $ -2,410 K
EBITDA, $ 17,580 K
60-Month Beta 1.20
% of Insider Shareholders 8.90%
% of Institutional Shareholders 96.63%
Float, K 12,997
% Float 91.10%
Short Volume Ratio 0.52

Growth:

1-Year Return 9.96%
3-Year Return -21.01%
5-Year Return -5.32%
5-Year Revenue Growth 25.98%
5-Year Earnings Growth -144.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/06/24
Next Earnings Date 11/13/24 [--]
Earnings Per Share ttm -0.33
EPS Growth vs. Prev Qtr 51.85%
EPS Growth vs. Prev Year -124.53%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 12/07/00

SRDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 226.82
Price/Earnings to Growth N/A
Return-on-Equity % -3.77%
Return-on-Assets % -2.54%
Profit Margin % -9.15%
Debt/Equity 0.25
Price/Sales 4.36
Price/Cash Flow 49.17
Price/Book 4.66
Book Value/Share 8.28
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar